SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-12-186435
Filing Date
2012-04-26
Accepted
2012-04-26 17:10:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 ON FORM S-3 TO FORM S-1 d341329dposam.htm POS AM 340117
2 CONSENT OF MARCUM LLP d341329dex231.htm EX-23.1 1908
3 CONSENT OF STONEFIELD JOSEPHSON, INC. d341329dex232.htm EX-23.2 1910
  Complete submission text file 0001193125-12-186435.txt   345244
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-167207 | Film No.: 12784480
SIC: 2834 Pharmaceutical Preparations